Lilly Walks Away As Roche Dominates EU’s COVID-19 Antibody Market

Sales Dwindled After Delta Fears

 
• By Andrew McConaghie
Eli Lilly logo sign atop Lilly Biotechnology Center
Lilly's revenues have exceed expectations this year thanks to US sales of its COVID-19 antibody therapy - but the picture is very different in Europe. • Source: Alamy

More from Business

More from Scrip